Comparison of the effectiveness of 2 substances articaine and mepivacaine on palatal Anesthesia by posterior superior alveolar nerve block on posterior of maxilla

Comparison of the effectiveness of 2 substances 4% articaine and 3% mepivacaine on palatal Anesthesia by posterior superior alveolar nerve block on posterior of maxilla

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170307032929N5

Enrollment

Registered

2021-02-23

Start date

2021-02-23

Completion date

Unknown

Last updated

2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Removal of posterior maxillary teeth.

Interventions

Intervention 1: Intervention group:a part of the posterior of the maxilla that receives 4% articaine anesthesia with epinephrine 1: 100000 and is produced by the elixir factory by PSA nerve block meth

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: People older than 18 years old Complete patient consent to participate in the study Those in whom upper posterior teeth is bilaterally indicated Indication of PSA block injection on both sides of the maxilla

Exclusion criteria

Exclusion criteria: Systemic and neurological diseases Allergy to sulfite (allergic asthma) or local anesthetic Smoking, alcohol, drugs Any acute infection and swelling

Design outcomes

Primary

Measure	Time frame
Palatal Anesthesia. Timepoint: 5 minutes after PSA block injection. Method of measurement: After 5 minutes with greater palatine injection, the paine has been recorded in VAS system.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFina Navi

Islamic Azad University

f_navi@dentaliau.ac.ir+98 912 201 5179

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026